Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Holder

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Diabetes Care|March 17, 2026
Hypercholesterolemia and Lipid-Lowering Therapy in Children and Adolescents With Type 1 Diabetes: Do We Implement Current Guidelines?Jantje Weiskorn, Marianne Becker, Clemens Kamrath, et al.
The Journal of Pediatrics|February 3, 2015
Comorbidity of type 1 diabetes and juvenile idiopathic arthritisGerhard Hermann, Angelika Thon, Kirsten Mönkemöller, et al.
The Journal of Pediatrics|December 24, 2018
Worse Metabolic Control and Dynamics of Weight Status in Adolescent Girls Point to Eating Disorders in the First Years after Manifestation of Type 1 Diabetes Mellitus: Findings from the Diabetes Patienten Verlaufsdokumentation RegistryThomas Reinehr, Barbara Dieris, Angela Galler, et al.
Pediatric Diabetes|April 26, 2020
Type 1 diabetes and epilepsy in childhood and adolescence: Do glutamic acid decarboxylase autoantibodies play a role? Data from the German/Austrian/Swiss/Luxembourgian DPV RegistryGideon John de Sousa, Sascha René Tittel, Martin Häusler, et al.
Pediatric Diabetes|January 27, 2022
Three-variate trajectories of metabolic control, body mass index, and insulin dose: Heterogeneous response to initiation of pump therapy in youth with type 1 diabetesMartin Tauschmann, Anke Schwandt, Nicole Prinz, et al.
The Journal of Clinical Endocrinology and Metabolism|May 7, 2009
Expanded clinical spectrum in hepatocyte nuclear factor 1b-maturity-onset diabetes of the youngKlemens Raile, Eva Klopocki, Martin Holder, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|August 26, 2014
Decreased levels of homoarginine and asymmetric dimethylarginine in children with type 1 diabetes: associations with cardiovascular risk factors but no effect by atorvastinAndreas Krebs, Jürgen Doerfer, Sarah Catherina Grünert, et al.
Journal of Diabetes Science and Technology|August 12, 2016
SPECTRUMBernhard Gehr, Martin Holder, Bernhard Kulzer, et al.
Plos One|August 18, 2016
20 Years of Pediatric Benchmarking in Germany and Austria: Age-Dependent Analysis of Longitudinal Follow-Up in 63,967 Children and Adolescents with Type 1 DiabetesBarbara Bohn, Beate Karges, Christian Vogel, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 27, 2012
(Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantationBritta Höcker, Stephan Böhm, Helmut Fickenscher, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Diabetes Care|March 17, 2026
Hypercholesterolemia and Lipid-Lowering Therapy in Children and Adolescents With Type 1 Diabetes: Do We Implement Current Guidelines?Jantje Weiskorn, Marianne Becker, Clemens Kamrath, et al.
The Journal of Pediatrics|February 3, 2015
Comorbidity of type 1 diabetes and juvenile idiopathic arthritisGerhard Hermann, Angelika Thon, Kirsten Mönkemöller, et al.
The Journal of Pediatrics|December 24, 2018
Worse Metabolic Control and Dynamics of Weight Status in Adolescent Girls Point to Eating Disorders in the First Years after Manifestation of Type 1 Diabetes Mellitus: Findings from the Diabetes Patienten Verlaufsdokumentation RegistryThomas Reinehr, Barbara Dieris, Angela Galler, et al.
Pediatric Diabetes|April 26, 2020
Type 1 diabetes and epilepsy in childhood and adolescence: Do glutamic acid decarboxylase autoantibodies play a role? Data from the German/Austrian/Swiss/Luxembourgian DPV RegistryGideon John de Sousa, Sascha René Tittel, Martin Häusler, et al.
Pediatric Diabetes|January 27, 2022
Three-variate trajectories of metabolic control, body mass index, and insulin dose: Heterogeneous response to initiation of pump therapy in youth with type 1 diabetesMartin Tauschmann, Anke Schwandt, Nicole Prinz, et al.
The Journal of Clinical Endocrinology and Metabolism|May 7, 2009
Expanded clinical spectrum in hepatocyte nuclear factor 1b-maturity-onset diabetes of the youngKlemens Raile, Eva Klopocki, Martin Holder, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|August 26, 2014
Decreased levels of homoarginine and asymmetric dimethylarginine in children with type 1 diabetes: associations with cardiovascular risk factors but no effect by atorvastinAndreas Krebs, Jürgen Doerfer, Sarah Catherina Grünert, et al.
Journal of Diabetes Science and Technology|August 12, 2016
SPECTRUMBernhard Gehr, Martin Holder, Bernhard Kulzer, et al.
Plos One|August 18, 2016
20 Years of Pediatric Benchmarking in Germany and Austria: Age-Dependent Analysis of Longitudinal Follow-Up in 63,967 Children and Adolescents with Type 1 DiabetesBarbara Bohn, Beate Karges, Christian Vogel, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 27, 2012
(Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantationBritta Höcker, Stephan Böhm, Helmut Fickenscher, et al.
Pageof 5